Related Experiment Video
Updated: Jun 23, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Streptococcus pneumoniae and Haemophilus influenzae at the initial stage of influenza
Misao Takano1, Kyoko Ozaki, Yoshiyuki Nitahara
1Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Insights
Drug-resistant Streptococcus pneumoniae and Haemophilus influenzae are common in children with influenza. Current vaccines may prevent some strains, but resistant non-typeable H. influenzae remains a concern.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Vaccinology
Background:
- Co-infections with Streptococcus pneumoniae and Haemophilus influenzae can increase influenza severity in children.
- While vaccinations for S. pneumoniae and H. influenzae were introduced in Japan in 2008, detailed characteristics of these pathogens during early influenza infection remain understudied.
Purpose of the Study:
- To investigate the prevalence, serotypes, and antimicrobial resistance of S. pneumoniae and H. influenzae in children with influenza.
- To compare findings in influenza-positive children with those in children with upper respiratory tract infections but without influenza.
Main Methods:
- Nasopharyngeal swabs were collected from children with influenza (n=236) and a control group with upper respiratory tract infections (n=189).
- Samples were analyzed for bacterial pathogens, including S. pneumoniae and H. influenzae, focusing on serotypes, drug susceptibilities, and resistance genes/mutations.
Main Results:
- S. pneumoniae, beta-streptococci, Staphylococcus aureus, Moraxella catarrhalis, and H. influenzae were isolated.
- Prevalent S. pneumoniae serotypes included 3, 6, 19, and 23, with penicillin, macrolide, and clindamycin resistance observed.
- H. influenzae type b showed significant ampicillin resistance; most isolates were non-typeable. Similar pathogen characteristics were noted in the control group.
Conclusions:
- Drug-resistant S. pneumoniae (serotypes 19, 23) and H. influenzae type b were present in the early stages of influenza infection, similar to non-influenza URTI cases.
- Current vaccines may offer protection against some identified strains.
- The prevalence of drug-resistant, non-typeable H. influenzae is a significant concern requiring further attention.
Background:
Streptococcus pneumoniae and Haemophilus influenzae infections in children with influenza have been noted because of the severity of co-infection. In Japan, vaccination against S. pneumoniae and H. influenzae infections has been listed in the vaccine program in 2008, but the characteristics of the two organisms, colonizing at the initial stage of influenza infection, have not been investigated in detail.
Methods:
Nasopharyngeal swabs from children with influenza (flu(+)) (n= 236; mean age, 6.2 years) were examined for bacterial pathogens, including S. pneumoniae and H. influenzae. They were then examined for serotypes, drug susceptibilities, and resistance genes (or gene mutations). As a reference, children with upper respiratory tract infection (URTI(+), flu(-); n = 189; mean age, 6.2 years) were also examined.
Results:
S. pneumoniae, beta-streptococci (groups A, B, and G), methicillin-susceptible and -resistant S. aureus, Moraxella catarrhalis, and H. influenzae were isolated. For S. pneumoniae, nine serotypes were detected with prevalent types of 3, 6, 19 and 23. Penicillin resistance was detected in types 19 and 23, while resistance to macrolide and clindamycin was found in various types. For H. influenzae, only b serotype was detected, with marked ampicillin resistance. The majority was non-typeable. Very similar results were obtained even in URTI(+) (flu(-)) cases.
Conclusion:
Multiple drug-resistant S. pneumoniae with major serotypes, for example, 19 and 23 and H. influenzae with serotype b were already present at the initial stage of influenza infection, similar to URTI(+) flu(-) cases. They could be prevented by current vaccines, but drug-resistant non-typeable H. influenzae is troubling.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Related Concept Videos
Influenza
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis I: Introduction
Atypical Pneumonia
Microbiota of the Respiratory Tract